Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
Zhang B, Yang Y, Shi X, Liao W, Chen M, Cheng AS, Yan H, Fang C, Zhang S, Xu G, Shen S, Huang S, Chen G, Lv Y, Ling T, Zhang X, Wang L, Zhuge Y, Zou X.
Zhang B, et al. Among authors: chen m, chen g.
Cancer Lett. 2015 Jan 28;356(2 Pt B):704-12. doi: 10.1016/j.canlet.2014.10.016. Epub 2014 Oct 23.
Cancer Lett. 2015.
PMID: 25449432